Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Cocrystal Pharma, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| Shares | 721.6K | 674.4K | −47.2K (−6.5%) |
| Value | $1.01M | $1.57M | +$557.3K (+55.0%) |
New holders (1)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Activest Wealth Management | 1 | $2 | 0.00% |
Sold out (3)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| UBS Group AG | 20,258 | $28.4K |
| Vima LLC | 231 | $461 |
| Wells Fargo & Company | 93 | $130 |